Generate a tailored SOP for Dr. Oliver Stone. Improve your application with a focused, well-structured draft.
Oliver Stone is a Wellcome Sir Henry Dale Fellow and PhD Group Leader in the Oxford Cardiovascular Science program. His research focuses on understanding the developmental processes that specify the array of heterogeneous cell subtypes found within the vertebrate vasculature. He studied neovascularization of adult tissues at the University of Bristol under David Bates and pursued postdoctoral training with Didier Stainier at the University of California, San Francisco, and at the Max Planck Institute for Heart and Lung Research. Using zebrafish and mouse models, his group identified the earliest known transcriptional regulator of endothelial/blood cell differentiation from the mesoderm, which is crucial for determining the eventual fate of these cells in the body. Funded by the Wellcome Trust and the Royal Society, his research aims to explore the impact of lineage history on the terminal fate and function of endothelial cells in blood and lymphatic vessels.
University of Oxford • Oxford, England
Leading research on developmental processes and cell differentiation in vertebrate vasculature.
Department of Politics and International Relations - Higher Level English requirement.